The echocardiographic assessment of functional mitral regurgitation
|
|
- Ashlie Primrose Higgins
- 6 years ago
- Views:
Transcription
1 European Journal of Echocardiography (2010) 11, i11 i17 doi: /ejechocard/jeq121 REVIEW The echocardiographic assessment of functional mitral regurgitation Simon Ray* University Hospitals of South Manchester, Manchester Academic Health Sciences Centre, Southmoor Road, Manchester M23 9LT, UK Received 8 September 2010; accepted after revision 9 September 2010 Functional mitral regurgitation (MR) is common, clinically important, and mechanistically complex. Its assessment by echocardiography can be challenging, and particular care is needed in the quantification of severity. Echocardiographers need to be aware of the potential limitations of flow convergence and vena contracta methods in assessing severity and alert to the prognostic importance of even moderate functional MR. Three-dimensional echocardiography has the potential to improve both the understanding of the mechanisms of functional MR and the accuracy of its quantification Keywords Mitral regurgitation Functional mitral regurgitation Ischaemic mitral regurgitation Introduction The purpose of this review is to discuss the echocardiographic assessment of functional mitral regurgitation (MR). It concentrates on some aspects that are particularly relevant and problematic in everyday practice. The recently published EAE guidelines give a full description of the assessment of MR. 1 Prevalence and prognostic significance Ischaemic heart disease is the most common cause of functional MR, but it can result from any condition that distorts the complex geometry of the mitral apparatus. Functional MR is common in the aftermath of both ST elevation and non-st elevation myocardial infarction. 2,3 It is often clinically silent and so may not be apparent unless echocardiography or other imaging is performed. In a community-based echocardiographic study, MR was present in 50% of patients within 30 days of MI and was moderate or severe in 12%, of whom one-third had no audible murmur. 2 The presence of Q waves, the location of the infarct, and the extent of CK elevation did not predict MR. In a study of patients with NSTEMI, the prevalence was similar at 42%. 3 Both in-hospital mortality and long-term outcome worsen with increasing severity of MR and moderate or severe MR is associated with a substantial increase in the occurrence of heart failure and death. 4 Grigioni et al. demonstrated that an ERO of 20 mmhg or an RVol of.30 ml are predictors of more than a doubling of mortality compared with patients without MR. This compares with the ERO of 40 mm 2 for prediction of a poor outcome in patients with degenerative valve disease. 5 In practical terms, anything more than mild functional MR has important prognostic implications. Mechanism and aetiology Functional or geometric MR occurs as a result of abnormalities not of the mitral valve itself but of the supporting left ventricular (LV) structures. Distortion of normal ventricular geometry results in failure of normal systolic leaflet coaptation and consequent regurgitation. The pathophysiology of functional MR is complex and results from the interplay of leaflet tethering as a result of distorted geometry, reduced closing forces as a result of impaired ventricular function, dyssynchronous contraction of the papillary muscles, and an enlarged orifice as a consequence of dilation of the mitral annulus. 6 Since these factors may alter during the cardiac cycle and with changes in loading conditions, functional MR is by nature dynamic. Using Carpentier s 7 classification, functional MR can result from type I, type II, or most commonly type IIIb dysfunction. Leaflet tethering: local vs. global remodelling Functional MR may be caused by any process that distorts ventricular geometry. The extent of distortion of the normal anatomy is a more important determinant of the degree of MR than the * Corresponding author. Tel: , simon.ray@uhsm.nhs.uk Published on behalf of the European Society of Cardiology. All rights reserved. & The Author For permissions please journals.permissions@oxfordjournals.org.
2 i12 S. Ray Table 1 Characteristics of mitral regurgitation due to asymmetric and symmetric tethering Asymmetric Symmetric... Aetiology Inferoposterior MI Multiple MI or non-ischaemic cardiomyopathy Tethering Marked posterior tethering of the posterior leaflet Both leaflets tethered and displaced apically Tenting Increased Markedly increased Annulus May be dilated Dilated, flattened, and decreased systolic contraction Remodelling Localized to inferoposterior wall Global dilation with increased sphericity MR jet Posteriorly directed, eccentric Usually central Figure 1 (A and B) Apical long-axis view showing marked asymmetric tethering of the posterior leaflet as a result of a limited inferoposterior myocardial infarction. There is failure of coaptation of the leaflets and malapposition as the tip of the anterior leaflet is on the atrial side of the posterior leaflet in systole. There is a jet of severe eccentric mitral regurgitation. degree of LV dysfunction. 8 A distinction can be drawn between functional MR produced by global ventricular dilation and that caused by localized abnormalities usually a result of inferoposterior myocardial infarction (Table 1). In general, the bigger the scar, the greater is the resulting distortion but even a relatively localized inferoposterior MI may result in localized scarring and distortion of the LV and severe eccentric functional MR (Figure 1A and B). 4,9 The scar and associated localized remodelling distort the normal geometry of the subvalvular apparatus, displacing the posteromedial papillary muscle posteriorly and apically. Since chordae from the posteromedial papillary muscle attach to both mitral leaflets the function of both is affected. The displacement of the papillary muscle tethers the posterior leaflet and pulls its tip in an apical and posterior direction. The body of the anterior leaflet is tethered by secondary chords and may develop a characteristic hockey stick (ice hockey rather than field hockey) appearance. As a result, the coaptation point of the leaflets is displaced posteriorly with respect to the centre of the LV cavity. The anterior leaflet slides above the tethered posterior leaflet and the result is malapposition of the leaflets with an eccentric, posteriorly directed jet of MR (Figure 1). Functional MR of this type is predominantly Carpentier 7 IIIb. The mechanism of MR in global LV dysfunction is different. Both papillary muscles are displaced posteriorly and apically to a similar extent with marked apical displacement of the coaptation line and resultant tenting of the leaflets (Figure 2A and B). 10 Since the displacement of both leaflet tips is similar, there is usually normal apposition of the leaflets and the regurgitant jet is central. The greater the extent of the tenting, the greater is the degree of MR (Figure 3). Global ventricular remodelling also leads to dilation and flattening of the mitral annulus. The normal mitral annulus contracts actively during systole and has a saddle shape that is important for maintenance of normal leaflet stresses. Loss of this complex three-dimensional (3D) structure increases leaflet stress. 11 The normal mitral valve also has considerable redundancy with respect to the annulus, such that the combined area of the leaflets is more than double that of the annulus. If annular dilation alone were the only abnormality present, considerable dilation would need to occur before significant MR developed. 12,13 However,
3 Echocardiographic assessment of functional MR i13 Figure 2 (A and B) Apical four-chamber view showing marked symmetrical bileaflet tethering with severely dilated left ventricle and a central jet of mitral regurgitation. There is failure of coaptation, but the tips of the leaflets are at the same level in systole. The short-axis views show failure of coaptation along the entire closure line of the valve with an elliptical regurgitant orifice. annular dilation worsens the degree of MR that occurs for any given displacement of the papillary apparatus and so is an important adjunctive mechanism. Closing forces The closing force on the mitral leaflets is an important factor in functional MR and especially in its dynamic variation throughout the cardiac cycle. 6 Closing force is generated by the systolic contraction of the ventricular myocardium driving blood against the valve and pushing the leaflets together. It opposes the tethering forces on the leaflets generated as a result of ventricular remodelling that tend to keep the leaflets apart. The severity of the MR depends on the balance of these opposing forces. A ventricle with relatively preserved function and hence a strong closing force may be able to overcome tethering and coapt the mitral
4 i14 S. Ray Figure 3 Measurement of the tenting area (within the white triangle) and the cooptation depth (double-headed white arrow) in the apical four-chamber view. Posterior leaflet angle is calculated as sin 21 (BC/AB). leaflets, whereas in a badly damaged heart, the tethering force will predominate with incomplete valve closure throughout systole, a larger regurgitant orifice, and more severe MR. This may then become a vicious cycle with worsening MR producing more ventricular dilation, more tethering, and still weaker closing forces. 6 Left ventricular dyssynchrony LV dyssynchrony may also contribute to functional MR, partly as a result of reduced closing force and partly as a result of disco-ordinate contraction of the papillary muscles, which results in dynamic tethering of the leaflets. 14 The true role of dyssynchrony in the pathogenesis of functional MR remains controversial. Mechanistic studies suggest that dyssynchrony is less important than remodelling and structural tethering, 15 but in selected patients, CRT does reduce the severity of functional MR which then tends to recur when CRT is withdrawn. 16 Dynamic nature of functional mitral regurgitation As described above, functional MR results from a complex interplay of geometric and contractile abnormalities and varies substantially not only with ventricular loading conditions but also during the cardiac cycle. 17 Good examples of the clinical relevance of this variability are the sometimes dramatic reduction in functional MR seen in patients under general anaesthesia and the correspondingly dramatic increase that can occur in some patients during exercise. It follows that functional MR must always be interpreted in the light of loading conditions and it is good practice to record the patient s blood pressure and drug treatment at the time of the echocardiogram. Pitfalls in the quantitative echocardiographic assessment of functional mitral regurgitation As discussed above, the degree of functional MR has important prognostic implications and quantitation is therefore important. Two factors in particular pose methodological difficulties in the assessment of the severity of functional MR and need to be understood if echocardiographic findings are to be correctly interpreted. Non-circular orifices As already described, the geometric distortions underlying functional MR tend to result in variable failure of coaptation along the closure line of the valve such that the regurgitant orifice is elliptical or slit-like as opposed to circular. The true situation may be even more complex with several separate regurgitant orifices along the closure line. The presence of non-circular orifices has important implications for the 2D assessment of the vena contracta and PISA as illustrated in Figure 4. The vena contracta is the narrowest part of the regurgitant jet as it passes through the orifice and the area of the vena contracta is the effective orifice area. 1 Conventionally, vena contracta is assessed in the parasternal long-axis view or apical three-chamber view where the colour jet is perpendicular to the ultrasound beam. For a circular orifice, this will give a reasonable estimate of severity but will underestimate the extent of regurgitation for an elliptical orifice. Figure 4 illustrates the possible extent of this underestimation and also the possible overestimation if a circular vena contracta is assumed in the apical two-chamber view along the long axis of the closure line. 18 3D echocardiography allows the direct planimetry of the
5 Echocardiographic assessment of functional MR i15 and relatively small in the centre. 19 Around a quarter have multiple separate PISAs. The exact pattern is determined by the underlying geometry of the valve. The implication again is that in this circumstance, 2D echocardiography will not provide an accurate estimate of the severity of regurgitation. Figure 4 Illustration of the impact of differing imaging plains on the assessment of orifice area in the short-axis view at the level of the mitral tips in a patient with severe global remodelling and symmetrical tethering. Assumption of a hemispherical PISA or circular vena contracta in the apical four-chamber view (plane of blue line) will give an estimated orifice area roughly equivalent to the blue circle. Assumption of a hemispherical PISA or circular vena contracta in the apical two-chamber view (plane of the red line) will give an estimated orifice area roughly equivalent to the red circle. Direct measurement of the vena contracta (using realtime three-dimensional echo) will give an estimated orifice area roughly the size of the gold ellipse. A similar area may be calculated using an elliptical formula for PISA. The three areas vary substantially and uncritical reliance on either vena contracta or PISA could result in either substantial underestimate or overestimate of the true severity of the regurgitation. vena contracta and greatly improves the accuracy of the assessment of the EROA. There is an excellent correlation between RVol derived from ERO measured by 3D planimetry and that measured using velocity-encoded cardiac magnetic resonance imaging (CMR). 19 2D echo on the other hand consistently underestimated both ERO and RVol. There is some preliminary evidence that the mean of the vena contract in the apical two- and fourchamber views correlates well with real-time 3D echo assessment, but this requires further clinical confirmation. 1 It should be noted that the separate vena contracta of multiple jets cannot be added together. A similar problem inevitably besets the measurement of PISA in functional MR. Around half of regurgitant valves have a PISA away from the midpoint of the closure line, and 35% have PISAs that are dominant in both the medial and lateral aspects of the closure line Dynamic mitral regurgitation during the cardiac cycle The dynamic nature of functional MR is a major challenge to quantification using standard flow convergence methods involving the measurement of proximal isovelocity area. Conventionally, the mid-systolic PISA coincident with the peak regurgitant velocity is used to estimate peak regurgitant flow rate and from that to derive maximal ERO and regurgitant stroke volume. This assumes that the mid-systolic PISA is maximal (i.e. that the ERO is largest and MR worst) in mid-systole, but the regurgitant flow rate in functional MR varies significantly during the cardiac cycle. 1 Typically, there are maxima in early and late systole and a minimum in mid-systole when there is improved coaptation due to maximal closing forces and the ERO becomes smaller. 17 So in functional MR, the mid-systolic PISA is generally the smallest and the true haemodynamic load of regurgitation will be underestimated if a single mid-systolic point is used. Similarly, the ERO will be overestimated if a maximal PISA in early or late systole that does not coincide with the mid-systolic peak regurgitant velocity is used to estimate peak regurgitant flow (Figure 5). In an elegant paper, Buck et al. 17 studied four different PISA methods to assess the severity of functional MR using volumetric CMR as the gold standard. Mid-systolic single time point estimates of PISA substantially underestimate the severity of MR compared with CMR. More accurate estimates were obtained with approaches that estimated the mean ERO during systole. The most practical, but still rather cumbersome, method used the technique of M-mode PISA to assess the ERO throughout systole. 17 This method requires that the M-mode cursor can be aligned perpendicular to the radius of the PISA and the plane of the ERO, is dependent on good image quality, and is not used routinely. Buck et al. also used a time-consuming reference PISA method whereby the CW spectral Doppler trace was superimposed on the M-mode PISA and serial calculations made of instantaneous ERO throughout systole to derive mean ERO. This method is too complex for clinical use, but it too underestimated mean ERO compared with CMR, most likely as a result of the presence of non-circular regurgitant orifices. 17 Alternative methods of quantification The volumetric method where aortic forward stroke volume is subtracted from total stroke volume through the mitral annulus to obtain the mitral regurgitant volume is an alternative. 1,20 This method gives an estimate of mean ERO throughout systole and so is independent of dynamic variations in ERO and orifice geometry but is highly dependent on accurate 2D measurements of the LVOT and the mitral annulus and thus also dependent on good
6 i16 S. Ray where surgical revascularization is being undertaken in those with moderate ischaemic MR at rest when the development of severe MR on exercise might prompt the addition of a mitral valve repair procedure. Figure 5 Illustration of the variation of the PISA and hence ERO during systole. In early and late systole, closing forces are relatively low and so the ERO and PISA relatively large. In midsystole, coincident with peak regurgitant velocity closing forces are maximal and so the ERO and PISA contract as the tips of the leaflets are forced closer together. image quality and subject to significant variability. For these reasons, it should not be regarded as a first-line technique. 1 Nonetheless, it is an important method and should be considered as an adjunct where there is apparently significant MR and either variation of MR severity during systole or a clearly non-circular orifice. Stress echo and functional mitral regurgitation Dobutamine stress echo may be useful in the assessment of functional MR to determine the extent of viable myocardium that might recover with revascularization, medical treatment, or possibly resynchronization. It is not so useful in assessing the severity of MR as it has direct effects on loading conditions. Exercise on the other hand is potentially very useful in assessing the clinical significance of functional MR and can provoke haemodynamically significant MR in patients who have only mild MR at rest. It is currently an underused technique. An exercise-induced increase in ERO of 13 mm 2 is associated with increased morbidity and mortality. 21 Exercise echo may be particularly useful in functional MR in three circumstances: 22 where the degree of exertional dyspnoea is out of keeping with the extent of LV dysfunction or degree of regurgitation at rest; where there is pulmonary oedema without an obvious cause; Echocardiographic reporting of functional mitral regurgitation The characteristics that should be noted in the echocardiographic assessment of functional MR are summarized in Table 2. Attention should be paid to all aspects of the valve apparatus and the underlying myocardium. The report should state if possible whether the mechanism is primarily localized remodelling or generalized LV dysfunction as this has potential bearing on management. However, the two are not always mutually exclusive as severe MR due initially to localized remodelling may lead over time to global ventricular dilation. Similarly, an extensive inferoposterior infarct may lead to both tethering of the posterior leaflet and global ventricular dilation. If CRT is being considered, it is worth assessing papillary muscle dyssynchrony but it is not justified as part of a routine assessment. A number of measurements of the mitral apparatus are potentially useful in assessing the likelihood of successful mitral valve repair but some caveats apply (Figure 3). Measurements of the coaptation depth, the tenting area, and the angle subtended by Table 2 Echo reporting in functional mitral regurgitation Left ventricle morphology and function LV volumes, shape, and ejection fraction Extent and localization of wall motion abnormalities including thinning consistent with scar If indicated Dyssynchrony Contractile reserve for identification of hibernating or stunned myocardium Deformation imaging for identification of hibernating or stunned myocardium Mitral valve morphology Coaptation depth Tenting area (ideally volume) Extent of tethering and posterior leaflet tethering angle. or, 45% (A4C view) Annular dimension (mid systole in A4C view) Direction of jet (or jets) Severity Caution to the dynamic nature of MR (NB loading conditions) Non-circular or multiple orifice Multiple or complex jets Quantify is possible (see text) Other features Left and right atrial size (volumes) RV function PA pressure Severity of TR
7 Echocardiographic assessment of functional MR i17 the posterior mitral leaflet in the apical four-chamber view have all been shown to predict the extent of MR and its recurrence after restrictive annuloplasty Tenting area varies with the echocardiographic view used and is maximal in the parasteral long-axis view. 23 In the apical four-chamber view, a coaptation depth of 1 cm, tenting area of 1.6 cm 2, and a posterior leaflet angle of.45% predict significant recurrent MR after annuloplasty. 23 Realtime 3D echo allows measurement of tenting volume and may be more accurate. 24 Interestingly, tenting volume has been shown to vary throughout systole in tandem with changes in the EROA confirming that the extent of tenting is fundamentally related to the severity of MR. 25 The principal pitfalls in the assessment of the severity of functional MR have been discussed in detail above. It is important to bear these in mind when reporting functional MR. In most patients, the danger is less of overreporting and more of underreporting severity and a holistic approach should be used with integration of all available information rather than reliance on a single parameter. It is also important for echocardiographers to recalibrate their eye when dealing with functional MR as moderate MR potentially has greater importance than it has in patients with organic MR. Calculations reliant on PISA or 2D assessments of the vena contracta should be treated with care and experienced echocardiographers should be practiced in the quantitative Doppler or volumetric method as a corroborative technique. Conclusions Functional MR, particularly ischaemic, is common and prognostically important while often clinically silent. It is important that echocardiographers understand the complex nature of the condition. Much important information can be obtained from a systematic assessment of the whole mitral apparatus and the underlying ventricular myocardium. It is by nature a dynamic problem and this makes assessment of severity difficult. Care must be taken not to underestimate its significance. Conflict of interest: none declared. References 1. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echo 2010;11: Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 2005;111: Perez de Isla L, Zamarano J, Quezada M, Almeira C, Rodrigo JC, Serra V et al. Prognostic significance of functional mitral regurgitation after non-st-segment elevation myocardial infarction acute coronary syndrome. Eur Heart J 2006;27: Grigioni F, Enriquez-Sarano M, Zehr KT, Daily A, Tajik AJ. Ischaemic mitral regurgitation: long-term outcome and prognostic implication with quantitative Doppler assessment. Circulation 2001;103: Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352: Levine RA, Schwammental E. Ischaemic mitral regurgitation on the threshold of a solution: from paradoxes to a unifying concept. Circulation 2005;112: Carpentier A. Cardiac valve surgery the French correction. J Thorac Cardiovasc Surg 1983;86: He S, Fontaine AA, Schwammental E, Yoganathan A, Levine RA. Integrated mechanism for functional MR: leaflet restriction versus coapting force: in vitro studies. Circulation 1997;96: Srichai MB, Grimm RA, Stillman AE, Gillinov AM, Rodriguez LL, Lieber ML et al. Ischaemic mitral regurgitation: impact of the left ventricle and mitral valve in patients with left ventricular systolic dysfunction. Ann Thorac Surg 2005;80: Watanabe N, Ogasawara Y, Yamaura Y, Kawamoto T, Toyota E, Akasaka T et al. Quantification of mitral valve tenting in ischaemic mitral regurgitation by transthoracic real time 3-D echocardiography. J Am Coll Cardiol 2005;45: Salgo IS, Gorman JH III, Gorman RC. Effect of annular shape and leaflet curvature in reducing mitral leaflet stress. Circulation 2002;39: He S, Lemmon JD, Weston MW, Jensen MO, Levine RA, Yoganathon AP. Mitral valve compensation for annular dilation: an in vitro study into the mechanisms of functional mitral regurgitation with an adjustable annulus model. J Heart Valve Dis 1999;8: Otsuji Y, Kamanohoro T, Yoshifuku S, Matsukada K, Koriyama C, Kisanuki A et al. Isolated annular dilation does not cause important functional mitral regurgitation. Comparison between patients with lone atrial fibrillation and those with idiopathic or ischaemic cardiomyopathy. J Am Coll Cardiol 2002;39: Kazaki H, Bazaz R, Scwartzman D, Dohbi K, Lif Sade L, Gorcsan J III. A mechanism for the immediate reduction in mitral regurgitation after cardiac resynchronisation therapy. J Am Coll Cardiol 2004;44: Agricola E, Oppizzi M, Galderissi M, Piasani M, Meris A, Pappone C et al. Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgitation in patients with left ventricular systolic dysfunction. Heart 2006; 92: Ypenberg C, Lancellotti P, Tupps LF, Bleeker EB, Hollman ER, Pierard LA et al. Acute effect of initiation and withdrawal of cardiac resynchronisation therapy in papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 2007; 50: Buck T, Plicht B, Kahlert P, Schenk IM, Hunold P, Erbel R. Effect of dynamic flow rate and orifice area on mitral regurgitation stroke volume quantification using the proximal isovelocity surface area method. J Am Coll Cardiol 2008;52: Kahlert P, Plicht B, Schenk IM et al. Direct measurement of size and shape of noncircular vena contracta area in functional versus organic mitral regurgitation using real time 3-dimensional echocardiography. J Am Soc Echo 2008;21: Song JM, Kim MT, Kim YT, Kang SH, Kim JJ, Kang DH et al. 3D characteristics of functional mitral regurgitation in patients with severe left ventricular dysfunction: a real time 3D colour Doppler echo study. Heart 2008;94: Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA et al. Recommendations for evaluation and severity of native valvular disease by 2-D and Doppler echocardiography. J Am Soc Echo 2003;16: Lancellotti P, Gerard PL, Pierard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005;26: Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol 2009;54: Magne J, Pibarot P, Dagenais F, Hachicha Z, Dumesnil JG, Senechal M. Peroperative posterior leaflet angle predicts outcome after restrictive annuloplasty for ischaemic mitral regurgitation. Circulation 2007;115: Agricola E, Oppizzi M, Maisamo F, De Boni, Schinkel AF, Torracca L et al. Echocardiographic classification of chronic ischaemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echo 2004;5: Song M, Fukada S, Kihara T, Shin MS, Garcia MJ, Thomas JD et al. Value of mitral valve tenting volume determined by 3-D echocardiography in patients with functional mitral regurgitation. Am J Cardiol 2006;98:
How to assess ischaemic MR?
ESC 2012 How to assess ischaemic MR? Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology University Hospital Sart Tilman, Liège ESC 2012 No conflict of interest Luc
More informationFunctional Mitral Regurgitation
Club 35 - The best in heart valve disease - Functional Mitral Regurgitation Steven Droogmans, MD, PhD UZ Brussel, Jette, Belgium 08-12-2011 Euroecho & other Imaging Modalities 2011 No conflicts of interest
More informationValvular Regurgitation: Can We Do Better Than Colour Doppler?
Valvular Regurgitation: Can We Do Better Than Colour Doppler? A/Prof David Prior St Vincent s Hospital Melbourne Sports Cardiology Valvular Regurgitation Valve regurgitation volume loads the ventricles
More informationMITRAL REGURGITATION ECHO PARAMETERS TOOL
Comprehensive assessment of qualitative and quantitative parameters, along with the use of standardized nomenclature when reporting echocardiographic findings, helps to better define a patient s MR and
More informationClinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun
Clinical Outcome of Tricuspid Regurgitation David Messika-Zeitoun I have financial relationships to disclose Consultant for: Edwards, Symetis and Valtech Tricuspid Regurgitation is a Common Finding Tricuspid
More informationDisclosures Rebecca T. Hahn, MD, FASE
The New ASE Guidelines for Native Valvular Regurgitation Mitral Regurgitation The New ASE Guidelines: Role of 2D/3D and CMR (With caveats and comments from R. Hahn) William A. Zoghbi MD, FASE, MACC Professor
More informationMitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System
Case Report Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System Antonio Chiricolo 1*, Leonard Y Lee 2 1 Department of Anesthesiology, Rutgers
More informationChronic Ischemic Mitral Regurgitation
Author: Please check highlighted matter in text. CHRONIC ISCHEMIC LV SYSTOLIC DYSFUNCTION Chronic Ischemic Mitral Regurgitation 16 CHAPTER Raluca Dulgheru, Patrizio Lancellotti INTRODUCTION Secondary Mitral
More informationQuantitation of Mitral Valve Tenting in Ischemic Mitral Regurgitation by Transthoracic Real-Time Three-Dimensional Echocardiography
Journal of the American College of Cardiology Vol. 45, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.11.048
More informationIndex. B B-type natriuretic peptide (BNP), 76
Index A ACCESS-EU registry, 158 159 Acute kidney injury (AKI), 76, 88 Annular enlargement, RV, 177 178 Annuloplasty chordal cutting, 113 complete ring, 99 etiology-specific ring, 100 evolution, 98 flexible
More informationIschemic Mitral Regurgitation
Ischemic Mitral Regurgitation Jean-Louis J. Vanoverschelde, MD, PhD Université catholique de Louvain Brussels, Belgium Definition Ischemic mitral regurgitation is mitral regurgitation due to complications
More informationWhat echo measurements are key prior to MitraClip?
APHP CHU Bichat - Claude Bernard What echo measurements are key prior to MitraClip? Eric Brochet,MD Cardiology Department Hopital Bichat Paris France No disclosure Conflict of interest Case 69 y.o man
More informationPrimary Mitral Regurgitation
EURO VALVE Madrid News from Valves Guidelines 2012: What s new and Why? Primary Mitral Regurgitation Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology Heart Valve Clinic,
More informationNew 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA
New 3D Quantification of Mitral Regurgitation Severity Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA No Financial Disclosures No off label discussion of devices
More informationTrue morphology of mitral regurgitant flow assessed by three- dimensional transesophageal echocardiography
DOI: 10.1111/echo.13395 ORIGINAL INVESTIGATION True morphology of mitral regurgitant flow assessed by three- dimensional transesophageal echocardiography Martin Lombardero M.D. Ruth Henquin D.L.S.H.T.M.,
More informationImaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015
Imaging MV Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 MV/MR: information needed on.. 1. MV anatomy 2. MR etiology - primary vs secondary 3. MR severity quantification
More informationSecondary MR joint with the mitral academy. What is new in our understanding of this disease? Luc Pierard University Hospital, Liège
Secondary MR joint with the mitral academy What is new in our understanding of this disease? Luc Pierard University Hospital, Liège Faculty disclosure Luc Pierard I have no financial relationships to disclose.
More informationProf. JL Zamorano Hospital Universitario Ramón y Cajal
Prof. JL Zamorano Hospital Universitario Ramón y Cajal Should we forget TR? Nath J et al. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004; 43:405-409 Why is it difficult
More informationDeterminants of Exercise-Induced Changes in Mitral Regurgitation in Patients With Coronary Artery Disease and Left Ventricular Dysfunction
Journal of the American College of Cardiology Vol. 42, No. 11, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.04.002
More informationGuidelines in perspective?
EuroValve 2016 Challenges in the management Secondary MR Guidelines in perspective? Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology, Liège, Belgium Heart Valve Clinic,
More informationPISA Evaluation of Mitral Regurgitation. Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011
PISA Evaluation of Mitral Regurgitation Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011 Introduction Evaluation of MR. What is PISA? Physiologic basis Issues
More informationChapter 20. JACC Cardiovasc Imaging 2009;2:
Chapter 20 Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance N Ajmone Marsan, J JM Westenberg, C Ypenburg,
More informationWhat are the best diagnostic tools to quantify aortic regurgitation?
What are the best diagnostic tools to quantify aortic regurgitation? Agnès Pasquet, MD, PhD Pôle de Recherche Cardiovasculaire Institut de Recherche Expérimentale et Clinique Université catholique de Louvain
More informationProfessors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo
Professors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo define the mechanism, quantify the regurgitation severity CP1293058-3
More informationQuantification of Functional Mitral Regurgitation by Real-Time 3D Echocardiography
JACC: CARDIOVASCULAR IMAGING VOL. 2, NO. 11, 2009 2009 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/09/$36.00 PUBLISHED BY ELSEVIER INC. DOI:10.1016/j.jcmg.2009.07.006 ORIGINAL RESEARCH
More informationQuantifying Aortic Regurgitation
Quantifying Aortic Regurgitation Linda D. Gillam, MD, MPH Morristown Medical Center Dorothy and Lloyd Huck Chair Cardiovascular Medicine Atlantic Health System No Disclosures 1 Valve Dysfunction Functional
More informationOutline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II
SURGICAL RISK IN VALVULAR HEART DISEASE: WHAT 2D AND 3D ECHO CAN TELL YOU AND WHAT THEY CAN'T Ernesto E Salcedo, MD Professor of Medicine University of Colorado School of Medicine Director of Echocardiography
More informationLUST trial. Echocardiography USER S MANUAL
LUST trial Echocardiography USER S MANUAL Rosa Sicari, Luna Gargani Ins1tute of Clinical Physiology Na1onal Council of Research, Pisa, Italy Parameters required (1) Aortic root Measurement of aortic root
More informationMITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)
UNIVERSITY OF PADUA, SCHOOL OF MEDICINE Department of Cardiac,Thoracic and Vascular Sciences Padua, Italy MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) Luigi P. Badano**, MD, PhD, FESC,
More informationEVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018
1 EVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018 David A. Orsinelli, MD, FACC, FASE Professor, Internal
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/20135 holds various files of this Leiden University dissertation. Author: Braun, Jerry Title: Surgical treatment of functional mitral regurgitation Issue
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationFunctional mitral regurgitation (MR), which occurs as a
Geometric Differences of the Mitral Apparatus Between Ischemic and Dilated Cardiomyopathy With Significant Mitral Regurgitation Real-Time Three-Dimensional Echocardiography Study Jun Kwan, MD; Takahiro
More informationIschaemic mitral regurgitation is a distinctive valve disease in that, unlike with organic
Correspondence to: Professor Bernard Iung, Service de Cardiologie, Groupe Hospitalier Bichat-Claude Bernard, 46, rue Henri-Huchard, 75877 Paris Cedex 18, France; bernard.iung@ bch.ap-hop-paris.fr Valve
More informationLV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION
LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION Jamilah S AlRahimi Assistant Professor, KSU-HS Consultant Noninvasive Cardiology KFCC, MNGHA-WR Introduction LV function assessment in Heart Failure:
More informationIoannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens
MITRAL REGURGITATION IN PATIENT WITH SEVERE AORTIC VALVE STENOSIS Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens I HAVE NOTHING TO DECLARE Management
More informationAssessment of LV systolic function
Tutorial 5 - Assessment of LV systolic function Assessment of LV systolic function A knowledge of the LV systolic function is crucial in the undertanding of and management of unstable hemodynamics or a
More informationWhen Does 3D Echo Make A Difference?
When Does 3D Echo Make A Difference? Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network 1 Practical Applications of 3D Echocardiography Recommended
More informationMR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras
MR echo case N.Koutsogiannis Department of Cardiology University Hospital Of Patras Case A 35 years old male came to the echo lab for a third opinion for his valvulopathy. He reports a long standing MR
More informationTricuspid and Pulmonary Valve Disease
Tricuspid and Pulmonary Valve Disease Lawrence Rudski MD FRCPC FACC FASE Professor of Medicine Director, Division of Cardiology Jewish General Hospital McGill University Right Sided Failure Edema Gut congestion
More informationDespite advances in our understanding of the pathophysiology
Suture Relocation of the Posterior Papillary Muscle in Ischemic Mitral Regurgitation Benjamin B. Peeler MD,* and Irving L. Kron MD,*, *Department of Cardiovascular Surgery, University of Virginia, Charlottesville,
More informationPercutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat
Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,
More informationMitral Regurgitation
Mitral Regurgitation Focus on Percutaneous Repair Steven J. Yakubov, MD FACC FSCAI System Chief, Structural Heart Diseaese, OhioHealth John H. McConnell Chair of Advanced Structural Heart Disease Medical
More informationJOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis
JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis Similarities and differences in Tricuspid vs. Mitral Valve Anatomy and Imaging. Echo evaluation
More informationRegurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA
Regurgitant Lesions Bicol Hospital, Legazpi City, Philippines July 2016 Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA Aortic Insufficiency Valve anatomy and function LVOT and
More informationExercise-Induced Changes in Degenerative Mitral Regurgitation
Journal of the American College of Cardiology Vol. 56, No. 4, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.12.073
More informationNEW GUIDELINES. A Guideline Protocol for the Assessment of Aortic Regurgitation From the British Society of Echocardiography Education Committee
NEW GUIDELINES A Guideline Protocol for the Assessment of Aortic Regurgitation From the British Society of Echocardiography Education Committee Gill Wharton, Prathap Kanagala (Lead Authors) Richard Steeds
More informationThe Edge-to-Edge Technique f For Barlow's Disease
The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele
More informationMITRAL STENOSIS. Joanne Cusack
MITRAL STENOSIS Joanne Cusack BSE Breakdown Recognition of rheumatic mitral stenosis Qualitative description of valve and sub-valve calcification and fibrosis Measurement of orifice area by planimetry
More information8/31/2016. Mitraclip in Matthew Johnson, MD
Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/21650 holds various files of this Leiden University dissertation. Author: Shanks, Miriam Title: Evolving imaging techniques for the assessment of cardiac
More informationΧειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας
Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation
More informationEchocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016
Echocardiographic Evaluation of the Cardiomyopathies Stephanie Coulter, MD, FACC, FASE April, 2016 Cardiomyopathies (CMP) primary disease intrinsic to cardiac muscle Dilated CMP Hypertrophic CMP Infiltrative
More informationMitral valve surgery has changed considerably in the past decades and is now indicated
Valve disease TIMING OF MITRAL VALVE SURGERY c POOR Correspondence to: Dr Maurice Enriquez-Sarano, Mayo Clinic, 2 First Street SW, Rochester, MN 5595, USA; sarano.maurice@mayo.edu Copyright 22 Mayo Foundation
More information좌심실수축기능평가 Cardiac Function
Basic Echo Review Course 좌심실수축기능평가 Cardiac Function Seonghoon Choi Cardiology Hallym university LV systolic function Systolic function 좌심실수축기능 - 심근의수축으로심실에서혈액을대동맥으로박출하는기능 실제임상에서 LV function 의의미 1Diagnosis
More informationThree-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation
Accepted Manuscript Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Wobbe Bouma, MD PhD, Robert C. Gorman, MD PII: S0022-5223(18)32805-8
More informationHemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics
Hemodynamic Assessment Matt M. Umland, RDCS, FASE Aurora Medical Group Milwaukee, WI Assessment of Systolic Function Doppler Hemodynamics Stroke Volume Cardiac Output Cardiac Index Tei Index/Index of myocardial
More informationLate secondary TR after left sided heart disease correction: is it predictibale and preventable
Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary
More informationClinical manifestations, diagnosis, and treatment of ischemic mitral regurgitation: a review
Review Article Clinical manifestations, diagnosis, and treatment of ischemic mitral regurgitation: a review Néstor Báez-Ferrer 1, María Manuela Izquierdo-Gómez 1, Belén Marí-López 1, Javier Montoto-López
More informationAATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville,
AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville, Virginia AATS Ischemic MR Guideline Writing Group Roster
More informationMarti McCulloch, BS, MBA, RDCS, FASE Houston, Texas
Marti McCulloch, BS, MBA, RDCS, FASE Houston, Texas Mitral Regurgitation What to Expect Review Specific Signs of Severity Supportive Signs of Severity Qualitative Parameters Structural Doppler Quantitative
More informationUncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency
Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency Rahul R. Jhaveri, MD, Muhamed Saric, MD, PhD, FASE, and Itzhak Kronzon, MD, FASE, New York, New York Background: Two-dimensional
More informationAortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants
Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants Martin G. Keane, MD, FASE Professor of Medicine Lewis Katz School of Medicine at Temple University Basic root structure Parasternal
More informationQuantification of MR
Valvular Regurgitation: Putting the New Guidelines into Practice James D. Thomas, MD, FACC, FASE, FESC Director, Center for Heart Valve Disease Bluhm Cardiovascular Institute Professor of Medicine, Feinberg
More informationCertificate in Clinician Performed Ultrasound (CCPU) Syllabus. Rapid Cardiac Echo (RCE)
Certificate in Clinician Performed Ultrasound (CCPU) Syllabus Rapid Cardiac Echo (RCE) Purpose: Rapid Cardiac Echocardiography (RCE) This unit is designed to cover the theoretical and practical curriculum
More informationWhen should we intervene surgically in pediatric patient with MR?
When should we intervene surgically in pediatric patient with MR? DR.SAUD A. BAHAIDARAH CONSULTANT, PEDIATRIC CARDIOLOGY ASSISTANT PROFESSOR OF PEDIATRICS HEAD OF CARDIOLOGY AND CARDIAC SURGERY UNIT KAUH
More informationI have financial relationships to disclose Honoraria from: Edwards
I have financial relationships to disclose Honoraria from: Edwards Mitral Valve Annuloplasty in Ischemic Mitral regurgitation Jean François Avierinos Hôpital Timone Marseille August 28, 2012 Ischemic MR
More informationDirect Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography
Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography Ertunc Altiok, Sandra Hamada, Silke van Hall, Mehtap Hanenberg, Eva Grabskaya, Michael Becker,
More informationInfluence of Chronic Tethering of the Mitral Valve on Mitral Leaflet Size and Coaptation in Functional Mitral Regurgitation
JACC: CARDIOVASCULAR IMAGING VOL. 5, NO. 4, BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. DOI:./j.jcmg.11..004 ORIGINAL RESEARCH Influence of Chronic
More informationRevealing new insights. irotate electronic rotation and xplane adjustable biplane imaging. Ultrasound cardiology. irotate and xplane
Ultrasound cardiology irotate and xplane Revealing new insights irotate electronic rotation and xplane adjustable biplane imaging Annemien van den Bosch and Jackie McGhie Department of Cardiology, Erasmus
More informationValvular Guidelines: The Past, the Present, the Future
Valvular Guidelines: The Past, the Present, the Future Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief,
More informationChronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches
European Journal of Cardio-thoracic Surgery 37 (2010) 170 185 Review Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches Wobbe Bouma a, *, Iwan
More informationTricuspid and Pulmonary Valve Disease
Tricuspid and Pulmonary Valve Disease Lawrence Rudski MD FRCPC FACC FASE Professor of Medicine Director, Division of Cardiology Jewish General Hospital McGill University Question 1 All of the following
More informationEcho in Asymptomatic Mitral and Aortic Regurgitation
2017 ASE Florida Orlando, FL October 9, 2017 10:40 11:00 PM 20 min Grand Harbor Ballroom South Echo in Asymptomatic Mitral and Aortic Regurgitation Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology
More informationDegenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention
Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral
More informationAortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -
Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo
More informationEvaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension
ESC Congress 2011.No 85975 Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension Second Department of Internal
More informationMitral regurgitation (MR) is a
Review Article Hellenic J Cardiol 2013; 54: 448-454 3D Vena Contracta Area to Quantify Severity of Mitral Regurgitation: A Practical New Tool? Dimitrios Maragiannis, Stephen H. Little The Methodist DeBakey
More informationUniversity of Groningen. New insights into the surgical treatment of mitral regurgitation Bouma, Wobbe
University of Groningen New insights into the surgical treatment of mitral regurgitation Bouma, Wobbe IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to
More informationLV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital
LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV inflow across MV LV LV outflow across AV LV LV geometric changes Pressure overload
More informationJ Cardiovasc Med 2012, 13: Received 19 October 2011 Revised 8 November 2011 Accepted 29 November 2011
Systematic review The importance of exercise echocardiography for clinical decision making in primary mitral regurgitation Caroline M. Van de Heyning, Julien Magne, Patrizio Lancellotti and Luc A. Piérard
More informationImprovements in outcomes for heart valve surgery, in particular mitral valve repair, have dictated
Imaging techniques DOPPLER ECHOCARDIOGRAPHIC ASSESSMENT OF VALVAR REGURGITATION c COLOUR Correspondence to: James D Thomas MD, Department of Cardiology, Desk F15, 9500 Euclid Avenue, The Cleveland Clinic
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/38522 holds various files of this Leiden University dissertation. Author: Ewe, See Hooi Title: Aortic valve disease : novel imaging insights from diagnosis
More informationICE: Echo Core Lab-CRF
APPENDIX 1 ICE: Echo Core Lab-CRF Study #: - Pt Initials: 1. Date of study: / / D D M M M Y Y Y Y 2. Type of Study: TTE TEE 3. Quality of Study: Poor Moderate Excellent Ejection Fraction 4. Ejection Fraction
More informationRIGHT VENTRICULAR SIZE AND FUNCTION
RIGHT VENTRICULAR SIZE AND FUNCTION Edwin S. Tucay, MD, FPCC, FPCC, FPSE Philippine Society of Echocardiography Quezon City, Philippines Echo Mission, BRTTH, Legaspi City, July 1-2, 2016 NO DISCLOSURE
More informationThe Key Questions in Mitral Valve Interventions. Where Are We in 2018?
The Key Questions in Mitral Valve Interventions Where Are We in 2018? Gilles D. DREYFUS, MD, FRCS, FESC Professor of Cardiothoracic Surgery 30 GIORNATE CARDIOLOGICHE TORINESI - OCT 2018 Are guidelines
More informationValve Analysis and Pathoanatomy: THE MITRAL VALVE
: THE MITRAL VALVE Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Washington University School of Medicine, St. Louis, MO Secretary, American Association for Thoracic Surgery
More informationMultiplane Two-Dimensional versus Real Time Three-Dimensional Transesophageal Echocardiography in Ischemic Mitral Regurgitation
DOI: 10.1111/j.1540-8175.2011.01528.x C 2011, Wiley Periodicals, Inc. Multiplane Two-Dimensional versus Real Time Three-Dimensional Transesophageal Echocardiography in Ischemic Mitral Regurgitation Khalil
More informationCASE REPORT: DOUBLE ORIFICE MITRAL VALVE WITH CLEFT IN ANTERIOR LEAFLET OF DOMINANT VALVE IN AN AFRO-CARIBBEAN
CASE REPORT: DOUBLE ORIFICE MITL VAE WITH CLEFT IN ANTERIOR LEAFLET OF DOMINANT VAE IN AN AFRO-CARIBBEAN Disclosure: No potential conflict of interest. Received: 27.08.13 Accepted: 23.06.14 Citation: EMJ
More informationEchocardiographic Evaluation of Primary Mitral Regurgitation
Echocardiographic Evaluation of Primary Mitral Regurgitation Roberto M Lang, MD 0-10 o ME 4CH Med A2 P2 50-70 o Commissural P3 P1 A2 80-100 o ME 2CH P3 A2 A1 A1 125-135 o - ME Long axis P2 A2 P3 A3 P2
More informationEchocardiography. Guidelines for Valve and Chamber Quantification. In partnership with
Echocardiography Guidelines for Valve and Chamber Quantification In partnership with Explanatory note & references These guidelines have been developed by the Education Committee of the British Society
More informationBogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010
Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania EAE Course, Bucharest, April 2010 This is how it started Mitral stenosis at a glance 2D echo narrow diastolic opening of MV leaflets
More informationThree-dimensional echocardiography in the clinical world
Three-dimensional echocardiography in the clinical world Dr. JL Zamorano Director CV Institute University Clinic SC, Madrid Advantages of 3D. Spatial manipulation. Optimal alineation of structures. Views
More informationLittle is known about the degree and time course of
Differential Changes in Regional Right Ventricular Function Before and After a Bilateral Lung Transplantation: An Ultrasonic Strain and Strain Rate Study Virginija Dambrauskaite, MD, Lieven Herbots, MD,
More informationThe difficult patient with mitral regurgitation
Clinical pathways The difficult patient with mitral regurgitation Stress echo can be the best tool Challenging cases Maria João Andrade, Lisbon PT Management of Severe Chronic Organic MR Echo Exercise
More informationObjectives. Diastology: What the Radiologist Needs to Know. LV Diastolic Function: Introduction. LV Diastolic Function: Introduction
Objectives Diastology: What the Radiologist Needs to Know. Jacobo Kirsch, MD Cardiopulmonary Imaging, Section Head Division of Radiology Cleveland Clinic Florida Weston, FL To review the physiology and
More informationIschemic Mitral Regurgitation
Ischemic Mitral Regurgitation 1 / 6 2 / 6 3 / 6 Ischemic Mitral Regurgitation Background Myocardial infarction (MI) can directly cause (IMR), which has been touted as an indicator of poor prognosis in
More informationAppendix II: ECHOCARDIOGRAPHY ANALYSIS
Appendix II: ECHOCARDIOGRAPHY ANALYSIS Two-Dimensional (2D) imaging was performed using the Vivid 7 Advantage cardiovascular ultrasound system (GE Medical Systems, Milwaukee) with a frame rate of 400 frames
More informationLeft atrial function. Aliakbar Arvandi MD
In the clinic Left atrial function Abstract The left atrium (LA) is a left posterior cardiac chamber which is located adjacent to the esophagus. It is separated from the right atrium by the inter-atrial
More information